UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 263

Sortiert nach

Glutathione and Related Molecules in Parkinsonism

International journal of molecular sciences, 2021-08, Vol.22 (16), p.8689

2021

Volltextzugriff (PDF)

Neuron-Astrocyte Interactions in Parkinson's Disease

Cells (Basel, Switzerland), 2020-12, Vol.9 (12), p.2623

2020

Volltextzugriff (PDF)

Serotonin 1A Receptors on Astrocytes as a Potential Target for the Treatment of Parkinson's Disease

Current medicinal chemistry, 2016-01, Vol.23 (7), p.686

2016

Volltextzugriff (PDF)

Chronic Systemic Exposure to Low-Dose Rotenone Induced Central and Peripheral Neuropathology and Motor Deficits in Mice: Reproducible Animal Model of Parkinson's Disease

International journal of molecular sciences, 2020-05, Vol.21 (9), p.3254

2020

Volltextzugriff (PDF)

Multifunctional Metallothioneins as a Target for Neuroprotection in Parkinson's Disease

Antioxidants, 2023-04, Vol.12 (4), p.894

2023

Volltextzugriff (PDF)

Neuroprotective effects of levetiracetam target xCT in astrocytes in parkinsonian mice

Journal of neurochemistry, 2016-01, Vol.136 (1), p.194-204

2016

Volltextzugriff (PDF)

Glial Cells as Possible Targets of Neuroprotection through Neurotrophic and Antioxidative Molecules in the Central and Enteric Nervous Systems in Parkinson's Disease

Acta medica Okayama, 2021-10, Vol.75 (5), p.549-556

2021

Volltextzugriff (PDF)

The neurotoxicity of psychoactive phenethylamines “2C series” in cultured monoaminergic neuronal cell lines

Forensic toxicology, 2020-07, Vol.38 (2), p.394-408

2020

Volltextzugriff (PDF)

3-O-Methyldopa inhibits astrocyte-mediated dopaminergic neuroprotective effects of L-DOPA

BMC neuroscience, 2016-07, Vol.17 (1), p.52-52, Article 52

2016

Volltextzugriff (PDF)

Anti-high mobility group box 1 antibody exerts neuroprotection in a rat model of Parkinson's disease

Experimental neurology, 2016-01, Vol.275, p.220-231

2016

Volltextzugriff (PDF)

N-Acetylcysteine Attenuates the Anxiety-Like Behavior and Spatial Cognition Impairment Induced by Doxorubicin and Cyclophosphamide Combination Treatment in Rats

Pharmacology, 2021-05, Vol.106 (5-6), p.286-293

2021

Volltextzugriff (PDF)

Attenuation of Macrophage Migration Inhibitory Factor-Stimulated Signaling via S-Nitrosylation

Biological and Pharmaceutical Bulletin, 2019/06/01, Vol.42(6), pp.1044-1047

2019

Volltextzugriff (PDF)

Targeting 5-HT1A receptors in astrocytes to protect dopaminergic neurons in parkinsonian models

Neurobiology of disease, 2013-11, Vol.59, p.244-256

2013

Volltextzugriff (PDF)

Approaches to Prevent Dopamine Quinone-Induced Neurotoxicity

Neurochemical research, 2009-04, Vol.34 (4), p.698-706

2009

Volltextzugriff (PDF)

The Rotenone Models Reproducing Central and Peripheral Features of Parkinson’s Disease

NeuroSci, 2020-08, Vol.1 (1), p.1-14

2020

Volltextzugriff (PDF)

Doxorubicin and cyclophosphamide treatment produces anxiety-like behavior and spatial cognition impairment in rats: Possible involvement of hippocampal neurogenesis via brain-derived neurotrophic factor and cyclin D1 regulation

Behavioural brain research, 2015-10, Vol.292, p.184-193

2015

Volltextzugriff (PDF)

Long-Term Systemic Exposure to Rotenone Induces Central and Peripheral Pathology of Parkinson’s Disease in Mice

Neurochemical research, 2015-06, Vol.40 (6), p.1165-1178

2015

Volltextzugriff (PDF)

Influence of 5-HT2A receptor function on anxiety-like behavior induced by a combination treatment with doxorubicin and cyclophosphamide in rats

Psychopharmacology, 2021-12, Vol.238 (12), p.3607-3614

2021

Volltextzugriff (PDF)

Region-Specific Neuroprotective Features of Astrocytes against Oxidative Stress Induced by 6-Hydroxydopamine

International journal of molecular sciences, 2019-01, Vol.20 (3), p.598

2019

Volltextzugriff (PDF)

Neuroprotective effect of fermented papaya preparation by activation of Nrf2 pathway in astrocytes

Nutritional neuroscience, 2018-03, Vol.21 (3), p.176-184

2018

Volltextzugriff (PDF)

Phosphorylated SARM1 is involved in the pathological process of rotenone-induced neurodegeneration

Journal of biochemistry (Tokyo), 2023-11, Vol.174 (6), p.533

2023

Volltextzugriff (PDF)

Protective Effects of Phytochemical Antioxidants Against Neurotoxin-Induced Degeneration of Dopaminergic Neurons

Journal of Pharmacological Sciences, 2014/03/20, Vol.124(3), pp.313-319

2014

Volltextzugriff (PDF)

Mirtazapine exerts astrocyte-mediated dopaminergic neuroprotection

Scientific reports, 2020-11, Vol.10 (1), p.20698, Article 20698

2020

Volltextzugriff (PDF)

Striatal astrocytes act as a reservoir for L-DOPA

PloS one, 2014-09, Vol.9 (9), p.e106362-e106362

2014

Volltextzugriff (PDF)

L-Theanine protects against excess dopamine-induced neurotoxicity in the presence of astrocytes

Journal of Clinical Biochemistry and Nutrition, 2016, Vol.59(2), pp.93-99

2016

Volltextzugriff (PDF)

1 – 25 von 263

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(234)
Mit Volltextzugriff
(240)

Publikationsform

Sprache

Englisch
(222)
Japanisch
(129)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Glutathione and Related Molecules in Parkinsonism

Neuron-Astrocyte Interactions in Parkinson's Disease

Serotonin 1A Receptors on Astrocytes as a Potential Target for the Treatment of Parkinson's Disease

Chronic Systemic Exposure to Low-Dose Rotenone Induced Central and Peripheral Neuropathology and Motor Deficits in Mice: Reproducible Animal Model of Parkinson's Disease

Multifunctional Metallothioneins as a Target for Neuroprotection in Parkinson's Disease

Neuroprotective effects of levetiracetam target xCT in astrocytes in parkinsonian mice

Glial Cells as Possible Targets of Neuroprotection through Neurotrophic and Antioxidative Molecules in the Central and Enteric Nervous Systems in Parkinson's Disease

The neurotoxicity of psychoactive phenethylamines “2C series” in cultured monoaminergic neuronal cell lines

3-O-Methyldopa inhibits astrocyte-mediated dopaminergic neuroprotective effects of L-DOPA

Anti-high mobility group box 1 antibody exerts neuroprotection in a rat model of Parkinson's disease

N-Acetylcysteine Attenuates the Anxiety-Like Behavior and Spatial Cognition Impairment Induced by Doxorubicin and Cyclophosphamide Combination Treatment in Rats

Attenuation of Macrophage Migration Inhibitory Factor-Stimulated Signaling via S-Nitrosylation

Targeting 5-HT1A receptors in astrocytes to protect dopaminergic neurons in parkinsonian models

Approaches to Prevent Dopamine Quinone-Induced Neurotoxicity

The Rotenone Models Reproducing Central and Peripheral Features of Parkinson’s Disease

Doxorubicin and cyclophosphamide treatment produces anxiety-like behavior and spatial cognition impairment in rats: Possible involvement of hippocampal neurogenesis via brain-derived neurotrophic factor and cyclin D1 regulation

Long-Term Systemic Exposure to Rotenone Induces Central and Peripheral Pathology of Parkinson’s Disease in Mice

Influence of 5-HT2A receptor function on anxiety-like behavior induced by a combination treatment with doxorubicin and cyclophosphamide in rats

Region-Specific Neuroprotective Features of Astrocytes against Oxidative Stress Induced by 6-Hydroxydopamine

Neuroprotective effect of fermented papaya preparation by activation of Nrf2 pathway in astrocytes

Phosphorylated SARM1 is involved in the pathological process of rotenone-induced neurodegeneration

Protective Effects of Phytochemical Antioxidants Against Neurotoxin-Induced Degeneration of Dopaminergic Neurons

Mirtazapine exerts astrocyte-mediated dopaminergic neuroprotection

Striatal astrocytes act as a reservoir for L-DOPA

L-Theanine protects against excess dopamine-induced neurotoxicity in the presence of astrocytes

Suchergebnisse filtern